Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy.
Demeria
Denny
D
Department of Gastroenterology, University of Alberta Liver Unit, Edmonton, Canada.
Birchall
Iain
I
Bain
Vincent G
VG
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D013792:Thalidomide
Hepatology. 2002 Sep;36(3):687-91
12198662
Cancer Chemother Pharmacol. 2006 Nov;58(5):654-64
16520988
Hepatology. 2003 Feb;37(2):429-42
12540794
Cancer. 2005 Feb 15;103(4):749-55
15660400
Anticancer Drugs. 2004 Jun;15(5):439-52
15166617
Biochem Pharmacol. 1998 Jun 1;55(11):1827-34
9714301
Oncology. 2003;65(3):242-9
14657598